ES2971281T3 - Composiciones para usar en el tratamiento de la osteoporosis y de fracturas óseas - Google Patents

Composiciones para usar en el tratamiento de la osteoporosis y de fracturas óseas Download PDF

Info

Publication number
ES2971281T3
ES2971281T3 ES17857493T ES17857493T ES2971281T3 ES 2971281 T3 ES2971281 T3 ES 2971281T3 ES 17857493 T ES17857493 T ES 17857493T ES 17857493 T ES17857493 T ES 17857493T ES 2971281 T3 ES2971281 T3 ES 2971281T3
Authority
ES
Spain
Prior art keywords
composition
ginger
citrulline
arginine
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17857493T
Other languages
English (en)
Spanish (es)
Inventor
Jacob Rajfer
Rebecca Rajfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K L R M LLC
Original Assignee
K L R M LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K L R M LLC filed Critical K L R M LLC
Application granted granted Critical
Publication of ES2971281T3 publication Critical patent/ES2971281T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES17857493T 2016-09-29 2017-09-29 Composiciones para usar en el tratamiento de la osteoporosis y de fracturas óseas Active ES2971281T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662401629P 2016-09-29 2016-09-29
US201762511601P 2017-05-26 2017-05-26
PCT/US2017/054284 WO2018064469A1 (en) 2016-09-29 2017-09-29 Compositions and methods for the treatment of orthopedic ailments

Publications (1)

Publication Number Publication Date
ES2971281T3 true ES2971281T3 (es) 2024-06-04

Family

ID=61760145

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17857493T Active ES2971281T3 (es) 2016-09-29 2017-09-29 Composiciones para usar en el tratamiento de la osteoporosis y de fracturas óseas

Country Status (9)

Country Link
US (3) US10426812B2 (OSRAM)
EP (1) EP3518951B1 (OSRAM)
JP (1) JP7075136B2 (OSRAM)
KR (1) KR102491748B1 (OSRAM)
CN (1) CN110087664B (OSRAM)
AU (1) AU2017336916A1 (OSRAM)
ES (1) ES2971281T3 (OSRAM)
IL (1) IL265571B (OSRAM)
WO (1) WO2018064469A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7075136B2 (ja) * 2016-09-29 2022-05-25 ケー．エル．アール．エム．，エルエルシー 整形外科疾患の治療のための組成物および方法
US20200246414A1 (en) * 2019-02-06 2020-08-06 K.L.R.M., Llc Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal system
CN112791171A (zh) * 2019-11-13 2021-05-14 内蒙古伊利实业集团股份有限公司 姜或其提取物用于防治骨质疏松的用途
CN119818501A (zh) * 2025-01-14 2025-04-15 北京大学口腔医学院 西地那非的新用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000191542A (ja) * 1998-12-25 2000-07-11 Lion Corp 骨粗鬆症予防、治療剤
US6210701B1 (en) 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
WO2004004648A2 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
WO2007070983A1 (en) * 2005-12-22 2007-06-28 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
US20120093950A1 (en) 2010-10-19 2012-04-19 Klrm, Llc Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occuring age related erectile dysfunction
US20120121740A1 (en) 2010-10-19 2012-05-17 K.L.R.M., Llc Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction
US20180078602A1 (en) * 2015-03-04 2018-03-22 K.L.R.M., Llc Methods and compositions for extending the efficacy of phosphodiesterase inhibitors for treating erectile dysfunction, and compositions for inhibiting the onset and slowing the progression of erectile dysfunction
JP7075136B2 (ja) * 2016-09-29 2022-05-25 ケー．エル．アール．エム．，エルエルシー 整形外科疾患の治療のための組成物および方法

Also Published As

Publication number Publication date
IL265571A (en) 2019-05-30
US20180104300A1 (en) 2018-04-19
AU2017336916A1 (en) 2019-04-18
US10426812B2 (en) 2019-10-01
CN110087664B (zh) 2022-11-01
EP3518951B1 (en) 2024-01-10
CN110087664A (zh) 2019-08-02
KR102491748B1 (ko) 2023-01-25
US20190381124A1 (en) 2019-12-19
KR20190061045A (ko) 2019-06-04
IL265571B (en) 2022-03-01
US10792324B2 (en) 2020-10-06
US20200215146A1 (en) 2020-07-09
JP7075136B2 (ja) 2022-05-25
JP2019529569A (ja) 2019-10-17
EP3518951A4 (en) 2020-05-27
EP3518951C0 (en) 2024-01-10
EP3518951A1 (en) 2019-08-07
WO2018064469A1 (en) 2018-04-05

Similar Documents

Publication Publication Date Title
US10792324B2 (en) Compositions and methods for the treatment of orthopedic ailments
ES2382115T3 (es) Formulación oral con efectos cardiovasculares beneficiosos, que comprende berberina
RS57684B1 (sr) Supstanca za održavanje zdravlja kosti i za lečenje osteoartritisa i osteoartroze zglobova
ES2549193T3 (es) Composiciones para tratar la disfunción eréctil
Hosseini et al. Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial
NZ562770A (en) Anti-inflammatory formulation comprising apocynin and paeonol
ES2769850T3 (es) Composición para prevenir o tratar la osteoartrosis
JP6286417B2 (ja) 非定型骨粗鬆症に対する予防又は治療剤
Rajfer et al. Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase: acceleration of fracture healing via inducible nitric oxide synthase
BR112017007364B1 (pt) Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico
EP2429537B1 (en) A fertilized, incubated avian egg or extract for the treatment of stress
KR102376603B1 (ko) 제니스테인 포스페이트 콘쥬게이트의 조성물의, 골량의 감소와 관련된 질환의 치료 또는 예방을 위한 사용 및 골 구조 및 골의 생체역학 강도를 개선하기 위한 사용
JP2014530223A (ja) 再生性、鎮痛性および／または抗炎症性を有する卵調製物
HU227182B1 (en) Lecitin-ascorbic acid combination
WO2015136319A1 (en) Use of organic sulphur, antioxidants, and amino acids in conjunction with exercise and electromagnetic stimulation to treat osteoporosis
Goel et al. Role of L arginine in treatment of osteoporosis
HK40010195B (en) Compositions and methods for the treatment of orthopedic ailments
ES2764177T3 (es) Arginina para su uso en el tratamiento y/o la prevención de la osteoartritis
HK40010195A (en) Compositions and methods for the treatment of orthopedic ailments
US20180333368A1 (en) Methods and compositions for treating and preventing arthritis
US20180193312A1 (en) Nutraceutical composition and dosing regimen
Yousefi-Manesh et al. The therapeutic effect of Astaxanthin on drill-induced closed femoral fracture model in male Wistar rats
Fee et al. Melatonin-analog, β-methyl-6-chloromelatonin, supplementation in spinal cord injury
KR20220064039A (ko) 척수 손상 예방 또는 치료용 조성물
DOWNEY Thwart POST-MEAL Bloating and Indigestion